Rates of malignancy associated with juvenile idiopathic arthritis and its treatment
T Beukelman, K Haynes, JR Curtis, F Xie… - Arthritis & …, 2012 - Wiley Online Library
Objective To determine the relative rates of incident malignancy among children with
juvenile idiopathic arthritis (JIA) with respect to treatment as compared to children without …
juvenile idiopathic arthritis (JIA) with respect to treatment as compared to children without …
Autoimmunity and cancer
R Masetti, A Tiri, A Tignanelli, E Turrini… - Autoimmunity …, 2021 - Elsevier
In many autoimmune rheumatic diseases, there is an increased risk of cancer compared to
the general population. The link between autoimmunity and cancer is dynamic and …
the general population. The link between autoimmunity and cancer is dynamic and …
Pharmacovigilance in juvenile idiopathic arthritis patients treated with biologic or synthetic drugs: combined data of more than 15,000 patients from Pharmachild and …
J Swart, G Giancane, G Horneff, B Magnusson… - Arthritis research & …, 2018 - Springer
Background The availability of methotrexate and the introduction of multiple biological
agents have revolutionized the treatment of juvenile idiopathic arthritis (JIA). Several …
agents have revolutionized the treatment of juvenile idiopathic arthritis (JIA). Several …
[HTML][HTML] Biologics in juvenile idiopathic arthritis-main advantages and major challenges: A narrative review
Juvenile idiopathic arthritis (JIA) is the most common rheumatic disease in childhood. The
disease is divided in different subtypes based on main clinical features and disease course …
disease is divided in different subtypes based on main clinical features and disease course …
Advances from clinical trials in juvenile idiopathic arthritis
Treatments available to children with juvenile idiopathic arthritis (JIA) have improved
dramatically in the past 15 years, largely because of the development of powerful new …
dramatically in the past 15 years, largely because of the development of powerful new …
Population-based cohort study on the risk of malignancy in East Asian children with juvenile idiopathic arthritis
VC Kok, JT Horng, JL Huang, KW Yeh, JJ Gau… - BMC cancer, 2014 - Springer
Background To investigate the association and magnitude of risk between JIA, its associated
treatment and cancer development in Taiwanese children. Methods Nationwide population …
treatment and cancer development in Taiwanese children. Methods Nationwide population …
What are the immunological consequences of long-term use of biological therapies for juvenile idiopathic arthritis?
JF Swart, S de Roock, NM Wulffraat - Arthritis Research & Therapy, 2013 - Springer
This review summarizes the immunological consequences of biological therapies used in
juvenile idiopathic arthritis (JIA). For every frequently used biological agent the …
juvenile idiopathic arthritis (JIA). For every frequently used biological agent the …
Juvenile idiopathic arthritis and malignancy
N Ruperto, A Martini - Rheumatology, 2014 - academic.oup.com
Biologic agents represent a major advance in the treatment of JIA. In 2008 a US Food and
Drug Administration (FDA) warning raised the hypothesis that anti-TNF therapies may be …
Drug Administration (FDA) warning raised the hypothesis that anti-TNF therapies may be …
[HTML][HTML] The risk of cancer in pediatric-onset immune-mediated inflammatory diseases–A nationwide study
A Ehrström, S Jansson, MH Jørgensen, V Wewer… - Journal of …, 2024 - Elsevier
Background and objectives Adult-onset immune-mediated inflammatory disease (IMID)
increases the risk of several cancers. However, data on pediatric-onset IMID (pIMID) …
increases the risk of several cancers. However, data on pediatric-onset IMID (pIMID) …
Juvenile idiopathic arthritis: management and therapeutic options
NM Ruth, MH Passo - Therapeutic advances in …, 2012 - journals.sagepub.com
The goals of treatment for juvenile idiopathic arthritis (JIA) include: suppression of
inflammation, achievement of remission, relief of pain, maintenance of function and doing so …
inflammation, achievement of remission, relief of pain, maintenance of function and doing so …